Form D · Biotechnology

Cleveland Diagnostics, Inc.

Cleveland, OH · CIK 0001637038

Offering snapshot reported Oct 20, 2025 · SEC filing

Reported sold
$14.4M
Offering amount: $14.4M
Investors reported
7
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 7, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 20, 2025Initial$14,421,653No comparison7SEC filing
Jan 31, 2024Initial$56,494,419No comparison26SEC filing
Dec 13, 2017Initial$0No comparison9SEC filing
Nov 23, 2016Initial$440,467No comparison5SEC filing
Mar 20, 2015Initial$1,980,000No comparison8SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-561369

Source: Form D, filed Oct 20, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Eli Arad Director
Ben Bronstein Director
Arnon Chait Director, Executive
Ilan Goldstein Director
Noel Jee Director
Levi Kushnir Director
Tim Longville Director
Jeffrey Marshall Director
Joseph Rich Director
Sameer Rohatgi Director
Karen Shanahan Executive
Andrew Summers Executive
Dara Wright Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
3615 Superior Avenue Ste 4407 B
Cleveland, OH, 44114